Processa Pharmaceuticals Closes $19.2 Million Public Offering
06 oct. 2020 16h05 HE
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, Oct. 06, 2020 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company focused on the development of drug products that are intended...